BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33310011)

  • 1. Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking.
    Jaccard M; Ehrbar S; Miralbell R; Hagen T; Koutsouvelis N; Poulsen P; Rouzaud M; Tanadini-Lang S; Tsoutsou P; Guckenberger M; Zilli T
    Radiother Oncol; 2021 Mar; 156():145-152. PubMed ID: 33310011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dosimetric error due to uncorrected tumor rotation during real-time adaptive prostate stereotactic body radiation therapy.
    Sengupta C; Skouboe S; Ravkilde T; Poulsen PR; Nguyen DT; Greer PB; Moodie T; Hardcastle N; Hayden AJ; Turner S; Siva S; Tai KH; Martin J; Booth JT; O'Brien R; Keall PJ
    Med Phys; 2023 Jan; 50(1):20-29. PubMed ID: 36354288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of action thresholds for electromagnetic tracking system-guided hypofractionated prostate radiotherapy using volumetric modulated arc therapy.
    Zhang P; Mah D; Happersett L; Cox B; Hunt M; Mageras G
    Med Phys; 2011 Jul; 38(7):4001-8. PubMed ID: 21858997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental investigation of dynamic real-time rotation-including dose reconstruction during prostate tracking radiotherapy.
    Muurholm CG; Ravkilde T; De Roover R; Skouboe S; Hansen R; Crijns W; Depuydt T; Poulsen PR
    Med Phys; 2022 Jun; 49(6):3574-3584. PubMed ID: 35395104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electromagnetic Transmitter-Based Prostate Gating for Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy: An Evaluation of Intrafraction Motion.
    De Bari B; Guibert G; Slimani S; Bashar Y; Risse T; Guisolan N; Trouillot J; Abel J; Weber P
    Curr Oncol; 2024 Feb; 31(2):962-974. PubMed ID: 38392066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trial.
    Hewson EA; Nguyen DT; O'Brien R; Poulsen PR; Booth JT; Greer P; Eade T; Kneebone A; Hruby G; Moodie T; Hayden AJ; Turner SL; Hardcastle N; Siva S; Tai KH; Martin J; Keall PJ
    Radiother Oncol; 2020 Oct; 151():234-241. PubMed ID: 32828839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMLC tracking and gating can improve dose coverage for prostate VMAT.
    Colvill E; Poulsen PR; Booth JT; O'Brien RT; Ng JA; Keall PJ
    Med Phys; 2014 Sep; 41(9):091705. PubMed ID: 25186380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of intrafraction prostate motion on clinical target coverage in proton therapy: A simulation study of dosimetric differences in two delivery techniques.
    Su Z; Slopsema R; Flampouri S; Li Z
    J Appl Clin Med Phys; 2019 Oct; 20(10):67-73. PubMed ID: 31478341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT.
    Hossain S; Xia P; Chuang C; Verhey L; Gottschalk AR; Mu G; Ma L
    Med Phys; 2008 Sep; 35(9):4041-8. PubMed ID: 18841856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geometric and dosimetric comparison of four intrafraction motion adaptation strategies for stereotactic liver radiotherapy.
    Nankali S; Worm ES; Hansen R; Weber B; Høyer M; Zirak A; Poulsen PR
    Phys Med Biol; 2018 Jul; 63(14):145010. PubMed ID: 29923837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric impact of intrafraction prostate rotation and accuracy of gating, multi-leaf collimator tracking and couch tracking to manage rotation: An end-to-end validation using volumetric film measurements.
    De Roover R; Hansen R; Crijns W; Muurholm CG; Poels K; Skouboe S; Haustermans K; Poulsen PR; Depuydt T
    Radiother Oncol; 2021 Mar; 156():10-18. PubMed ID: 33264640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate SBRT With Intrafraction Motion Management Using a Novel Linear Accelerator-Based MV-kV Imaging Method.
    Gorovets D; Burleson S; Jacobs L; Ravindranath B; Tierney K; Kollmeier M; McBride S; Happersett L; Hunt M; Zelefsky M
    Pract Radiat Oncol; 2020; 10(5):e388-e396. PubMed ID: 32454176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy.
    Zhang P; Hunt M; Happersett L; Yang J; Zelefsky M; Mageras G
    Phys Med Biol; 2013 Nov; 58(21):7803-13. PubMed ID: 24145674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
    Dubouloz A; Rouzaud M; Tsvang L; Verbakel W; Björkqvist M; Linthout N; Lencart J; Pérez-Moreno JM; Ozen Z; Escude L; Zilli T; Miralbell R
    Radiat Oncol; 2018 Jun; 13(1):114. PubMed ID: 29921291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy using a hydrogel spacer for localized prostate cancer: A dosimetric comparison between tomotherapy with the newly-developed tumor-tracking system and cyberknife.
    Manabe Y; Hashimoto S; Mukouyama H; Shibamoto Y
    J Appl Clin Med Phys; 2021 Oct; 22(10):66-72. PubMed ID: 34415658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulated real-time dose reconstruction for moving tumors in stereotactic liver radiotherapy.
    Skouboe S; Poulsen PR; Muurholm CG; Worm E; Hansen R; Høyer M; Ravkilde T
    Med Phys; 2019 Nov; 46(11):4738-4748. PubMed ID: 31468543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single institution's dosimetry and IGRT analysis of prostate SBRT.
    Wu QJ; Li T; Yuan L; Yin FF; Lee WR
    Radiat Oncol; 2013 Sep; 8():215. PubMed ID: 24034234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential monoscopic image-guided motion compensation in tomotherapy stereotactic body radiotherapy (SBRT) for prostate cancer.
    Lu L; Chao E; Zhu T; Wang AZ; Lian J
    Med Phys; 2023 Jan; 50(1):518-528. PubMed ID: 36397645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate bed and organ-at-risk deformation: Prospective volumetric and dosimetric data from a phase II trial of stereotactic body radiotherapy after radical prostatectomy.
    Yoon S; Cao M; Aghdam N; Shabsovich D; Kahlon S; Ballas L; Collins S; Steinberg ML; Kishan AU
    Radiother Oncol; 2020 Jul; 148():44-50. PubMed ID: 32311600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.